Literature DB >> 29478298

Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.

M L Arnold1, A Kainz2, L G Hidalgo3, F Eskandary2, N Kozakowski4, M Wahrmann2, H Haslacher5, R Oberbauer2, A Heilos6, B M Spriewald7, P F Halloran8, G A Böhmig2.   

Abstract

Fc-dependent effector mechanisms may contribute to antibody-mediated rejection (ABMR), and distinct gene polymorphisms modifying the function of Fc gamma receptors (FcγRs) may influence the capability of donor-specific antibodies (DSAs) to trigger inflammation. To evaluate the relevance of functional FcγR variants in late ABMR, 85 DSA-positive kidney allograft recipients, who were recruited upon antibody screening of 741 prevalent patients, were genotyped for polymorphisms in FcγRIIA (FCGR2A-H/R131 ; rs1801274), FcγRIIIA (FCGR3A-V/F158 ; rs396991), and FcγRIIIB (FCGR3B-neutrophil antigen 1 ([NA1]/NA2; rs35139848). Individuals with high-affinity FCGR3A-V158 alleles (V/V158 or V/F158 ) showed a higher rate (and extent) of peritubular capillaritis (ptc) in protocol biopsies than homozygous carriers of the lower-affinity allele (ptc score ≥1: 53.6% vs 25.9%; P = .018). Associations were independent of C1q-binding to DSA or capillary C4d. In parallel, there was a trend toward increased macrophage- and injury-repair response-associated transcript subsets. Kidney function over 24 months, however, was not different. In support of a functional role of FcγRIIIA polymorphism, NK92 cells expressing FCGR3A-V158 produced >2 times as much interferon gamma upon incubation with HLA antibody-coated cells as those expressing FCGR3A-F158 . FcγRIIA and FcγRIIIB polymorphisms were not associated with allograft morphology. Our data suggest that the presence of high-affinity FcγRIIIA variants may favor DSA-triggered microcirculation inflammation.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  alloantibody; genetics; histocompatibility; kidney transplantation/nephrology; protocol biopsy; rejection: antibody-mediated (ABMR); translational research/science

Year:  2018        PMID: 29478298     DOI: 10.1111/ajt.14710

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

1.  Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients.

Authors:  Marie-Luise Arnold; Falko M Heinemann; Simon Oesterreich; Benjamin Wilde; Anja Gäckler; David Goldblatt; Bernd M Spriewald; Peter A Horn; Oliver Witzke; Monika Lindemann
Journal:  Vaccines (Basel)       Date:  2022-05-05

2.  Missing Self and DSA-Synergy of Two NK Cell Activation Pathways in Kidney Transplantation.

Authors:  Luis G Hidalgo
Journal:  J Am Soc Nephrol       Date:  2021-01-07       Impact factor: 10.121

3.  FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.

Authors:  Pascale Paul; Pascal Pedini; Luc Lyonnet; Julie Di Cristofaro; Anderson Loundou; Mathieu Pelardy; Agnes Basire; Françoise Dignat-George; Jacques Chiaroni; Pascal Thomas; Martine Reynaud-Gaubert; Christophe Picard
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

Review 4.  Results and reflections from the PROfiling Consortium on Antibody Repertoire and Effector functions in kidney transplantation: A mini-review.

Authors:  Elena G Kamburova; Andries Hoitsma; Frans H Claas; Henny G Otten
Journal:  HLA       Date:  2019-06-18       Impact factor: 4.513

Review 5.  Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.

Authors:  Anat R Tambur; Patricia Campbell; Anita S Chong; Sandy Feng; Mandy L Ford; Howard Gebel; Ronald G Gill; Garnett Kelsoe; Vasilis Kosmoliaptsis; Roslyn B Mannon; Michael Mengel; Elaine F Reed; Nicole M Valenzuela; Chris Wiebe; I Esme Dijke; Harold C Sullivan; Peter Nickerson
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 8.086

6.  The FCGR3A 158 V/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection.

Authors:  Nicolle Litjens; Annemiek Peeters; Judith Kal-van Gestel; Mariska Klepper; Michiel Betjes
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

Review 7.  Role of Fcγ receptors in HER2-targeted breast cancer therapy.

Authors:  Antonino Musolino; William J Gradishar; Hope S Rugo; Jeffrey L Nordstrom; Edwin P Rock; Fernanda Arnaldez; Mark D Pegram
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

8.  Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival.

Authors:  Markus Wahrmann; Bernd Döhler; Marie-Luise Arnold; Sabine Scherer; Katharina A Mayer; Susanne Haindl; Helmuth Haslacher; Georg A Böhmig; Caner Süsal
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

9.  Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome.

Authors:  Hannes Vietzen; Bernd Döhler; Thuong Hien Tran; Caner Süsal; Philip F Halloran; Farsad Eskandary; Carsten T Herz; Katharina A Mayer; Nicolas Kozakowski; Markus Wahrmann; Sarah Ely; Susanne Haindl; Elisabeth Puchhammer-Stöckl; Georg A Böhmig
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

Review 10.  Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms.

Authors:  Emilie Lebraud; Maëva Eloudzeri; Marion Rabant; Baptiste Lamarthée; Dany Anglicheau
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.